Tokushima, Japan

Masanori Kawasaki

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 41(Granted Patents)


Location History:

  • Ishii, JP (2007 - 2012)
  • Tokushima, JP (2015)
  • Osaka, JP (2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Masanori Kawasaki: Innovator in Recombinant Baculovirus Vaccines

Introduction

Masanori Kawasaki is a prominent inventor based in Tokushima, Japan, known for his significant contributions to the field of biotechnology. With a total of six patents to his name, Kawasaki has been at the forefront of developing innovative solutions for infectious diseases.

Latest Patents

One of his most notable inventions is the recombinant baculovirus vaccine. This invention provides a novel transfer vector and recombinant baculovirus, along with methods for their production. The vaccines developed from this invention aim to serve as preventive or therapeutic drugs against infectious diseases such as malaria and influenza. The technology includes a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene, controlled by a dual promoter. Furthermore, the pharmaceuticals containing the recombinant baculovirus are geared towards effective treatment methods for combating these infectious diseases.

Career Highlights

Masanori Kawasaki has made significant strides in his career through his work at several esteemed organizations, particularly Otsuka Pharmaceutical Company Limited and the Educational Foundation Jichi Medical University. His experiences at these institutions have greatly contributed to his expertise in developing innovative vaccines and methodologies.

Collaborations

Throughout his career, Kawasaki has collaborated with various professionals in the field. Notably, he has worked alongside Makoto Matsumoto and Hiroyuki Hashizume, both of whom have also contributed to advancements in medical research and biotechnology.

Conclusion

In conclusion, Masanori Kawasaki stands out as a key innovator in the realm of recombinant baculovirus vaccines. His dedication to developing effective therapeutic solutions for infectious diseases showcases the potential of biotechnology in improving global health. With a promising trajectory and a commitment to innovation, Kawasaki continues to make impactful contributions to the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…